Managing vascular risk factors among obese quitters with diabetes: how intensive lifestyle intervention and novel pharmacotherapy can work in concert
Obese smokers with diabetes are a special risk category for all-cause mortality and major adverse cardiovascular events (MACE). Weight loss and smoking cessation are key interventions advocated for the management of diabetes in almost all the guidelines across the globe. However, there is a substant...
Main Authors: | Kar, D, Seidu, S, Davies, M, Khunti, K |
---|---|
Format: | Journal article |
Language: | English |
Published: |
ABCD
2017
|
Similar Items
-
Relationship of cardiometabolic parameters in non-smokers, current smokers, and quitters in diabetes: a systematic review and meta-analysis
by: Kar, D, et al.
Published: (2016) -
The cost‐effectiveness of pharmacotherapy and lifestyle intervention in the treatment of obesity
by: Minyi Lee, et al.
Published: (2020-04-01) -
Lifestyle or pharmacotherapy in cardio-metabolic disease prevention
by: Borenyi S. Seidu, et al.
Published: (2023-06-01) -
Designing an intervention to help the quitters quit: A qualitative, intervention co-design study
by: Judith Dyson, et al.
Published: (2023-12-01) -
Quitter ou réformer la zone Franc?
by: Fatou Gueye, et al.